The Votes Are In!
2024 Readers' Choice is back, bigger and better than ever!
View Winners → Tech Oct 23, 2024
Photo by Blocks Fletcher on Unsplash
by
share with
The Apple Watch, often touted as the champion of smartwatches, continues to redefine its role in personal health monitoring with the introduction of the Series 10. Its upgraded features promise to enhance the way users engage with their health data.
The Series 10 is markedly bigger, brighter, and slimmer than its predecessors. Central to Apple Watch’s health monitoring is its capability to measure heart rates, perform ECGs, track steps, monitor sleep, and now, assess risks associated with sleep apnea.
Despite its growing suite of health functionalities, the Apple Watch cannot be marketed as a medical device—due in part to regulatory barriers enforced by the Food and Drug Administration (FDA). To be considered a medical device, the Apple Watch would need FDA approval, usually accompanied by a doctor’s prescription.
Still, the Apple Watch Series 10 has not stifled enthusiasm. Users have creatively linked FDA-approved devices such as Dexcom’s blood-glucose sensors with their watches, allowing individuals with Type 1 diabetes to monitor their glucose levels conveniently. It provides a live feed of blood sugar levels, acting as an invaluable tool in chronic illness management.
Series 10’s enhanced capabilities surge alongside evolving technology, hinting at future innovations such as blood pressure and blood glucose monitoring. These prospective developments could cement the smartwatch’s role as an indispensable health tool.
The Series 10 is priced at a starting price of about $400.
